Yamauchi K, Komuta R, Tanabe H, Yokoyama M, et al. Real-world Outcomes of Durvalumab Consolidation in Elderly Patients With Unresectable NSCLC Following CCRT With Daily Low-dose Carboplatin. Anticancer Res 2025;45:369-378.
PMID: 39740815